Renaissance Technologies - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 165 filers reported holding GENOMIC HEALTH INC in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q3 2019$169,692,000
+3.6%
2,502,100
-11.1%
0.14%0.0%
Q2 2019$163,719,000
-1.8%
2,814,500
+18.3%
0.14%
-5.3%
Q1 2019$166,684,000
+32.9%
2,379,500
+22.2%
0.15%
+10.9%
Q4 2018$125,413,000
+0.2%
1,947,100
+9.2%
0.14%
+6.2%
Q3 2018$125,209,000
+16.1%
1,783,100
-31.1%
0.13%
+118.6%
Q2 2018$107,812,000
+191.4%
2,587,524
+118.8%
0.06%
+47.5%
Q1 2018$37,004,000
+6.9%
1,182,600
+16.9%
0.04%
+5.3%
Q4 2017$34,610,000
+23.9%
1,012,000
+16.2%
0.04%
+15.2%
Q3 2017$27,941,000
+5.5%
870,700
+7.1%
0.03%
-2.9%
Q2 2017$26,473,000
+14.7%
813,300
+10.9%
0.03%
+6.2%
Q1 2017$23,088,000
+36.2%
733,200
+27.1%
0.03%
+18.5%
Q4 2016$16,949,000
+7.0%
576,700
+5.3%
0.03%
-3.6%
Q3 2016$15,837,000
+40.2%
547,600
+25.6%
0.03%
+33.3%
Q2 2016$11,293,000
+2.2%
436,100
-2.2%
0.02%0.0%
Q1 2016$11,048,000
+8.4%
446,021
+54.0%
0.02%
-4.5%
Q4 2015$10,194,000
+106.1%
289,600
+23.9%
0.02%
+83.3%
Q3 2015$4,947,000
-33.4%
233,800
-12.5%
0.01%
-29.4%
Q2 2015$7,425,000
+558.8%
267,200
+624.1%
0.02%
+750.0%
Q1 2015$1,127,000
+189.0%
36,900
+202.5%
0.00%
+100.0%
Q4 2014$390,000
-86.4%
12,200
-88.8%
0.00%
-85.7%
Q1 2014$2,859,000
+84.7%
108,555
+105.2%
0.01%
+75.0%
Q4 2013$1,548,000
+33.9%
52,901
+39.9%
0.00%
+33.3%
Q3 2013$1,156,000
-78.2%
37,800
-77.4%
0.00%
-78.6%
Q2 2013$5,296,000167,0000.01%
Other shareholders
GENOMIC HEALTH INC shareholders Q2 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$56,620,0005.32%
Baker Brothers Advisors 13,655,618$386,590,0004.87%
NORTH TIDE CAPITAL, LLC 1,500,000$42,465,0003.24%
Murphy Michael R 291,292$8,246,0002.85%
Tributary Capital Management, LLC 111,244$3,149,0000.66%
Champlain Investment Partners, LLC 1,234,780$34,957,0000.61%
IRONBRIDGE CAPITAL MANAGEMENT LP 454,085$12,855,0000.34%
STONEBRIDGE CAPITAL MANAGEMENT INC 27,180$769,0000.30%
Motley Fool Asset Management LLC 36,179$1,139,0000.24%
Kimelman & Baird, LLC 35,800$1,013,0000.19%
View complete list of GENOMIC HEALTH INC shareholders